Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases

BACKGROUND: Among patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC), incidence of brain metastases (BMs) is relatively high and increasing. Despite the high unmet need for patients with HER2+ MBC and BMs, real-world data on treatment patterns and...

Descripción completa

Detalles Bibliográficos
Autores principales: DeBusk, Kendra, Ike, Chiemeka, Lindegger, Nicolas, Schwartz, Naomi, Surinach, Andy, Liu, Yutong, Forero-Torres, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373006/
https://www.ncbi.nlm.nih.gov/pubmed/35621719
http://dx.doi.org/10.18553/jmcp.2022.28.6.657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373006/
https://www.ncbi.nlm.nih.gov/pubmed/35621719
http://dx.doi.org/10.18553/jmcp.2022.28.6.657

Ejemplares similares